[ Price : $8.95]
FDA warns Scottsdale, AZ-based Surgenex about CGMP and other violations in its production and distribution of cellular products fo...[ Price : $8.95]
Federal Register notice: FDA proposes to reclassify human immunodeficiency virus viral load monitoring tests from Class 3 to Class...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled Investigational New Drug Applications ...[ Price : $8.95]
FDA has approved Takedas Livtencity as the first approved treatment for adults and pediatric patients with post-transplant cytomeg...[ Price : $8.95]
FDA approves an Aadi Bioscience NDA for Fyarro (sirolimus protein-bound particles for injectable suspension) for treating adult pa...[ Price : $8.95]
Pfizer asks a California federal court for an injunction against an ex-employee it says took confidential information and trade se...[ Price : $8.95]
FDA places a partial clinical hold a Kura Oncology Phase 1b study (KOMET-001) of KO-539 in patients with relapsed or refractory ac...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Immunomedics breast cancer ...